Dentox , Inc. was founded in 2003 by Howard Katz, DDS, to introduce the use of Botulinum Toxin Type A for Dentistry applications. Howard Katz, D.D.S. is considered internationally as one of the foremost experts and the authority on the dentofacial use of Botulinum toxins and injectible fillers. Dr Katz created many of the original patented protocols that have been acquired by Allergan Inc.for the use of botulinum toxins in the dentofacial realm. "Botulinium Toxins, Botox, Dentistry, TMJ, TMJ Symptoms, Treating TMJ Symptoms with BOTOX, TMJ and BOTOX, injectible fillers, dentofacial, peri-cranial muscle pain, parafunctional clenching, BTX-A (Allergan, Inc - BOTOX® ), BTX-B ( Elan , Inc - Myobloc T ), BTX-A ( Dysport® - Ipsen , Ltd., Bath , UK )

Home | About Dentox | History of Dentox | Contact Dentox
Basic Neurotoxins Science Educational Opportunities For Your Practice Course Descriptions Why Dentox?
Articles Private Patients Dental Legal issues
Why Dentox?

  1. Many dental diseases and failed dental treatments are a result of aberrant muscle function

  2. Many of the Botulinum treatment protocols for peri-cranial muscle pain , TMD and the implications of parafunctional clenching that are taught around the world were created by Dr. Katz

  3. Muscle diseases of the masticatory system are best taught from a dental and a neurological perspective

  4. The program taught by DENTOX is specific to the dental profession

  5. Predictable control of aberrant neuro-muscular forces is achievable with botulinum neurotoxins.

  6. Dentists are best trained to recognize and treat diseases of the masticatory system

  7. Patients have poor compliance with intra- oral devices

  8. The center for Evidence Based Dentistry strongly recommends avoiding major treatment for transient conditions like myogenic TMD

  9. Most patients are unwilling to having comprehensive irreversible treatments for transient conditions

  10. Botulinum toxins A and B have a long standing heritage of safety

 

 Botulinum Toxins (Botox) For Dentistry

Dentox , Inc. was founded in 2003 by Howard Katz, DDS, to introduce the use of Botulinum Toxin Type A for Dentistry applications. Howard Katz, D.D.S. is considered internationally as one of the foremost experts and the authority on the dentofacial use of Botulinum toxins and injectible fillers. Dr Katz created many of the original patented protocols that have been acquired by Allergan Inc.for the use of botulinum toxins in the dentofacial realm. "Botulinium Toxins, Botox, Dentistry, TMJ, TMJ Symptoms, Treating TMJ Symptoms with BOTOX, TMJ and BOTOX, injectible fillers, dentofacial, peri-cranial muscle pain, parafunctional clenching, BTX-A (Allergan, Inc - BOTOX® ), BTX-B ( Elan , Inc - Myobloc T ), BTX-A ( Dysport® - Ipsen , Ltd., Bath , UK )